Institute of Cancer Research
The Institute of Cancer Research (ICR), based in Great Britain, is a leading cancer research organisation dedicated to advancing the understanding and treatment of cancer. Founded in 1909, the ICR has made significant contributions to the field, including the development of innovative therapies and pioneering research in cancer genetics and drug discovery. With its headquarters in London and operational regions across the UK, the ICR focuses on a range of critical areas, including cancer biology, clinical trials, and personalised medicine. Its unique approach combines cutting-edge research with a commitment to translating findings into effective treatments, positioning the ICR as a key player in the global fight against cancer. Notable achievements include numerous breakthroughs in targeted therapies, solidifying its reputation as a world-class institution in oncology research.
DitchCarbon Score
How does Institute of Cancer Research's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Institute of Cancer Research's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Institute of Cancer Research's reported carbon emissions
The Institute of Cancer Research, headquartered in Great Britain, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. As of now, there are no emissions figures provided, indicating a lack of disclosed Scope 1, 2, or 3 emissions data. Additionally, there are no commitments to science-based targets (SBTi) or other climate pledges documented. Without specific emissions data or reduction initiatives, it is unclear how the Institute of Cancer Research is addressing its carbon footprint or contributing to climate action within the healthcare and research sectors. The absence of this information suggests a potential area for improvement in transparency and commitment to sustainability practices.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Institute of Cancer Research is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
